DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Leukeran (Chlorambucil) - Mouth Ulceration - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Mouth Ulceration (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Leukeran (Chlorambucil) where reactions include mouth ulceration. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Leukeran side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-19

Patient: female

Reactions: Mouth Ulceration, Hypophagia, Dehydration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Matulane
    Dosage: 150 mg, unk
    Administration route: Oral
    Start date: 2012-01-06

Leukeran
    Dosage: unk
    Administration route: Oral
    Start date: 2012-01-01

Velcade
    Dosage: unk
    Start date: 2012-01-01



Possible Leukeran side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-02

Patient: female

Reactions: Dehydration, Hypophagia, Mouth Ulceration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: unk
    Start date: 2012-01-01

Leukeran
    Dosage: unk
    Administration route: Oral
    Start date: 2012-01-01

Matulane
    Dosage: 150 mg, unk
    Administration route: Oral
    Start date: 2012-01-06



Possible Leukeran side effects in 62 year old female

Reported by a physician from United States on 2012-02-10

Patient: 62 year old female

Reactions: Hypophagia, Dehydration, Mouth Ulceration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: iv
    Indication: Hodgkin's Disease
    Start date: 2012-01-01

Matulane
    Dosage: 150 mg;qd;po
    Administration route: Oral
    Indication: Hodgkin's Disease
    Start date: 2012-01-06

Leukeran
    Dosage: po
    Administration route: Oral
    Indication: Hodgkin's Disease
    Start date: 2012-01-01



Possible Leukeran side effects in 48 year old female

Reported by a physician from United States on 2011-10-28

Patient: 48 year old female

Reactions: Renal Failure, Nausea, Mouth Ulceration, Anaemia, Squamous Cell Carcinoma of Skin, Neutropenia, Rash, Accidental Exposure

Drug(s) suspected as cause:
Dapsone
    Dosage: titrated up to 100 mg twice daily, titrated up to 50 mg daily
    Indication: Behcet's Syndrome

Arava
    Dosage: 20 mg daily
    Indication: Behcet's Syndrome

Imuran
    Dosage: titrated up to 150 mg daily
    Indication: Behcet's Syndrome

Plaquenil
    Dosage: 300 mg daily, 200 mg daily, 200 mg twice daily, oral
    Administration route: Oral
    Indication: Behcet's Syndrome

Enbrel
    Dosage: 25 mg twice weekly
    Indication: Behcet's Syndrome

Methotrexate
    Dosage: 7.5 mg per week, titrated up to 20 mg per week
    Indication: Behcet's Syndrome

Cytoxan
    Dosage: 250 mg, 250 mg, 500 mg, 750 mg, 1000 mg, 1250 mg, intravenous
    Indication: Behcet's Syndrome

Cyclosporine
    Indication: Behcet's Syndrome
    End date: 2001-01-06

Remicade
    Dosage: 200 mg, 300 mg, 400 mg, intravenous
    Indication: Behcet's Syndrome

Leukeran
    Dosage: titrated up to 4 mg daily, 3 mg daily, 3 mg daily
    Indication: Behcet's Syndrome

Colchicine
    Dosage: 6 mg twice daily, 6 mg twice daily
    Indication: Behcet's Syndrome

Cellcept
    Dosage: 1000 mg twice daily
    Indication: Behcet's Syndrome

Rituxan
    Dosage: 1000 mg, 1000 mg, intravenous
    Indication: Behcet's Syndrome
    End date: 2006-07-05

Prednisone
    Dosage: 10 mg daily
    Indication: Behcet's Syndrome

Other drugs received by patient: Terbutaline Sulfate; (Esomeprazole); Pregabalin; Acyclovir; (Fentanyl); Erythromycin; Sertraline Hydrochloride; Theophylline; Pentoxifylline; Furosemide; Folic Acid; Fluticasone Propionate / Salmeterol; Ipratropium Bromide and Albuterol Sulfate

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017